User:Mr. Ibrahem/Vericiguat

Vericiguat, sold under the brand name Verquvo, is a medication used in heart failure after a recent worsening to reduce the risk of heart related death and hospitalization. It is only used in those with an ejection fraction less than 45%. It is taken by mouth.

Common side effects include low blood pressure and low red blood cells. Use in pregnancy may harm the baby. It is a soluble guanylate cyclase (sGC) stimulator, and should not be used with other medications in this class.

Vericiguat was approved for medical use in the United States and Europe in 2021. In the United States it costs about 615 USD per month as of 2022. This amount in the United Kingdom costs the NHS about £100.